AbbVie’s SKYRIZI[®] (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis January 13, 2025
Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD January 9, 2025
Why financial literacy is important for students: 5 courses to help them become money-smart adults November 21, 2024
‘Forever chemicals’ linked to poor sleep among young adults in first-of-its-kind study October 28, 2024
Depression challenges the work and functional capacity of young adults in Finland both at work and in leisure time October 21, 2024
